logo

KZIA

Kazia Therapeutics·NASDAQ
--
--(--)
--
--(--)
3.73 / 10
Netural

Analyst sentiment is overwhelmingly bullish with a 100% 'Strong Buy' rating from one analyst, yet historical win rates are poor (0.0%). Fund-flow assessment is good (7.46/10); small, medium, and large inflow trends are positive, but block and extra-large patterns lean negative. This divergence between optimistic analyst views and mixed fund-flow signals calls for careful interpretation and additional data before making investment decisions.

FundamentalSentiment(3.73)Technical
Fund Flow Rating
Analyst RatingStrong Buy

Wall Street Opinions

Strong Buy

Strong Buy

100%

Buy

0%

Hold

0%

Sell

0%

Strong Sell

0%

Date2026-01-28
InstitutionHC Wainwright & Co.
Times predicted3
Historical Win Rate0.0%
What is the analyst consensus for KZIA?
  • KZIA holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.73/10 (Netural).